Athira Pharma Total Shareholders Equity 2011-2026 | ATHA

Annual Total Shareholders Equity Athira Pharma

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
44.8 M	130 M	235 M	321 M	274 M	-19.7 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
321 M	-19.7 M	164 M

Quarterly Total Shareholders Equity Athira Pharma

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
26.8 M	32 M	37.3 M	44.8 M	57.6 M	83.3 M	107 M	130 M	155 M	185 M	211 M	235 M	262 M	281 M	302 M	321 M	336 M	351 M	363 M	274 M	274 M	274 M	274 M	-19.7 M	-19.7 M	-17.4 M	-	-14.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
363 M	-19.7 M	168 M

Total Shareholders Equity of other stocks in the Biotechnology industry

Issuer	Total Shareholders Equity	Price	% 24h	Market Cap	Country
Acer Therapeutics ACER	-16.8 M	-	2.71 %	$ 14 M	USA
MorphoSys AG MOR	621 M	-	2.43 %	$ 254 M	Germany
Adaptimmune Therapeutics plc ADAP	39.5 M	-	-15.15 %	$ 60.3 M	Britain
Adverum Biotechnologies ADVM	70.7 M	-	-	$ 86.2 M	USA
ANI Pharmaceuticals ANIP	404 M	$ 80.34	-	$ 1.55 B	USA
Acasti Pharma ACST	66.6 M	-	4.01 %	$ 150 M	Canada
Aptorum Group Limited APM	21.1 M	$ 0.84	1.96 %	$ 4.58 M	China
I-Mab IMAB	1.72 B	-	-	$ 866 M	China
Applied Genetic Technologies Corporation AGTC	29.5 M	-	-	$ 26.5 M	USA
Adagene ADAG	50.5 M	$ 2.67	-	$ 150 M	China
Biophytis SA BPTS	2.27 M	-	-13.47 %	$ 169 M	France
AlloVir ALVR	113 M	-	4.14 %	$ 49.1 M	USA
Midatech Pharma plc MTP	6.72 M	-	-18.52 %	$ 27.3 M	Britain
Ampio Pharmaceuticals AMPE	3.36 M	-	-11.43 %	$ 502 K	USA
Alterity Therapeutics Limited ATHE	35.5 M	$ 3.57	-	$ 8.59 B	Australia
Applied Molecular Transport AMTI	60.8 M	-	-	$ 10.1 M	USA
ARCA biopharma ABIO	382 M	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	-158 M	-	-24.86 %	$ 820 K	USA
Akero Therapeutics AKRO	750 M	-	-	$ 3.67 B	USA
Aeglea BioTherapeutics AGLE	518 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	-30.6 M	$ 1.5	-	$ 281 M	USA
Aptose Biosciences APTO	-4.54 M	-	-45.71 %	$ 1.2 M	Canada
Albireo Pharma ALBO	176 M	-	-0.23 %	$ 916 M	USA
Ascendis Pharma A/S ASND	884 M	$ 222.03	-	$ 5 B	Danmark
Allena Pharmaceuticals ALNA	18.9 M	-	3.16 %	$ 1.9 M	USA
Aptinyx APTX	38.3 M	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	10.7 M	-	-13.39 %	$ 1.45 M	USA
BioNTech SE BNTX	1.37 B	$ 110.34	-	$ 27.2 B	Germany
Cabaletta Bio CABA	236 M	$ 2.44	-	$ 2.85 M	USA
Arena Pharmaceuticals ARNA	673 M	-	-6.81 %	$ 3.04 B	USA
Aridis Pharmaceuticals ARDS	-24.2 M	-	17.91 %	$ 11.1 M	USA
Burford Capital Limited BUR	1.7 B	$ 8.97	-	$ 1.44 B	Britain
AgeX Therapeutics AGE	5.47 M	-	-10.17 %	$ 12.2 K	USA
Athersys ATHX	16.4 M	-	3.77 %	$ 22.4 M	USA
Akouos AKUS	234 M	-	0.23 %	$ 488 M	USA
Avenue Therapeutics ATXI	2.8 M	-	-52.27 %	$ 4.45 M	USA
Can-Fite BioPharma Ltd. CANF	5.44 M	$ 4.22	-	$ 9.18 B	Israel
Autolus Therapeutics plc AUTL	427 M	$ 1.46	-	$ 373 M	Britain
Compugen Ltd. CGEN	54.9 M	$ 1.71	-	$ 153 M	Israel
Amneal Pharmaceuticals AMRX	-109 M	$ 14.52	-	$ 4.49 B	USA
AIkido Pharma AIKI	39.9 M	-	1.93 %	$ 17.4 M	USA
AVROBIO AVRO	94.7 M	-	1083.1 %	$ 745 M	USA
CureVac N.V. CVAC	688 M	-	-	$ 867 M	Germany
Alpine Immune Sciences ALPN	179 M	-	-	$ 2.17 B	USA
Ayala Pharmaceuticals AYLA	-1.1 M	-	-	$ 7.46 M	Israel